G. Sacchi

Microalbuminuria identifies overall cardiovascular risk in essential hypertension: an artificial neural network-based approach.

G. Leoncini, G. Sacchi, F. Viazzi, 2002, Journal of hypertension.

Genetic polymorphism of the renin-angiotensin system and organ damage in essential hypertension.

R. Ravazzolo, G. Leoncini, G. Sacchi, 2000, Kidney international.

Predicting cardiovascular risk using creatinine clearance and an artificial neural network in primary hypertension

G. Leoncini, G. Sacchi, F. Viazzi, 2005, Journal of hypertension.

Prevalence and clinical correlates of microalbuminuria in essential hypertension: the MAGIC Study. Microalbuminuria: A Genoa Investigation on Complications.

G. Sacchi, F. Viazzi, M. Ravera, 1997, Hypertension.

Microalbuminuria: a marker of cardiovascular risk and organ damage in essential hypertension.

G. Sacchi, F. Viazzi, C. Tomolillo, 1997, Kidney international. Supplement.

Microalbuminuria is an early marker of target organ damage in essential hypertension.

G. Sacchi, F. Viazzi, M. Ravera, 1998, American journal of hypertension.

Prevalence and Clinical Correlates of Microalbuminuria in Essential Hypertension The MAGIC Study

G. Sacchi, F. Viazzi, M. Ravera, 1997 .

The deletion polymorphism of the angiotensin I-converting enzyme gene is associated with target organ damage in essential hypertension.

R. Ravazzolo, G. Sacchi, F. Viazzi, 1996, Journal of the American Society of Nephrology : JASN.

Microalbuminuria is an integrated marker of subclinical organ damage in primary hypertension

G. Leoncini, G. Sacchi, F. Viazzi, 2002, Journal of Human Hypertension.